Global Rapid Microbiology Testing Market to Reach $6.2 Billion by 2027
Abstract: - Global Rapid Microbiology Testing Market to Reach $6. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Rapid Microbiology Testing estimated at US$3.
New York, June 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Rapid Microbiology Testing Industry" - https://www.reportlinker.com/p06032734/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Kits segment is readjusted to a revised 7.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 10.4% CAGR
- The Rapid Microbiology Testing market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
- Consumables Segment to Record 6.8% CAGR
- In the global Consumables segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$644.9 Million in the year 2020 will reach a projected size of US$988.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$849.4 Million by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.
- Select Competitors (Total 32 Featured) -
Abbott
BD
bioMérieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Gen-Probe Inc.
Merck KGaA
Quidel Corporation
Siemens Healthcare GmbH
Sysmex
Thermo-Fisher Scientific Inc.
Read the full report: https://www.reportlinker.com/p06032734/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Rapid Microbiology
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Rapid Microbiology Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Rapid Microbiology
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027
Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Reagents & Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Reagents & Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Reagents & Kits by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 16: World Current & Future Analysis for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Contract Research
Organizations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Diagnostic
Laboratories & Hospitals by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Diagnostic Laboratories &
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Diagnostic Laboratories &
Hospitals by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 25: World Current & Future Analysis for Growth-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Growth-based by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 27: World 15-Year Perspective for Growth-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Viability-based
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Viability-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Viability-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Cellular
Component-based by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 32: World Historic Review for Cellular Component-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Cellular
Component-based by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 34: World Current & Future Analysis for Nucleic
Acid-based by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 35: World Historic Review for Nucleic Acid-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 36: World 15-Year Perspective for Nucleic Acid-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 37: World Current & Future Analysis for Other Methods by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 38: World Historic Review for Other Methods by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 39: World 15-Year Perspective for Other Methods by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 40: USA Current & Future Analysis for Rapid Microbiology
Testing by Product - Instruments, Reagents & Kits and
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 41: USA Historic Review for Rapid Microbiology Testing by
Product - Instruments, Reagents & Kits and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 42: USA 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 43: USA Current & Future Analysis for Rapid Microbiology
Testing by End-Use - Pharma & Biotech Companies, Contract
Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 44: USA Historic Review for Rapid Microbiology Testing by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 45: USA 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 46: USA Current & Future Analysis for Rapid Microbiology
Testing by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 47: USA Historic Review for Rapid Microbiology Testing by
Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 48: USA 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
CANADA
Table 49: Canada Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 50: Canada Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 51: Canada 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 52: Canada Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 53: Canada Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 54: Canada 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 55: Canada Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 56: Canada Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 57: Canada 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
JAPAN
Table 58: Japan Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 59: Japan Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 60: Japan 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 61: Japan Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 62: Japan Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 63: Japan 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 64: Japan Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 65: Japan Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 66: Japan 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
CHINA
Table 67: China Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 68: China Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 69: China 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 70: China Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 71: China Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 72: China 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 73: China Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 74: China Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 75: China 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
EUROPE
Table 76: Europe Current & Future Analysis for Rapid
Microbiology Testing by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 77: Europe Historic Review for Rapid Microbiology Testing
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 78: Europe 15-Year Perspective for Rapid Microbiology
Testing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027
Table 79: Europe Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 80: Europe Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 83: Europe Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 84: Europe 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 85: Europe Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 86: Europe Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 87: Europe 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
FRANCE
Table 88: France Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 89: France Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 90: France 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 91: France Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 92: France Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 93: France 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 94: France Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 95: France Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 96: France 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
GERMANY
Table 97: Germany Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 98: Germany Historic Review for Rapid Microbiology
Testing by Product - Instruments, Reagents & Kits and
Consumables Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 99: Germany 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 100: Germany Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 101: Germany Historic Review for Rapid Microbiology
Testing by End-Use - Pharma & Biotech Companies, Contract
Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 102: Germany 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 103: Germany Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 104: Germany Historic Review for Rapid Microbiology
Testing by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 105: Germany 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
ITALY
Table 106: Italy Current & Future Analysis for Rapid
Microbiology Testing by Product - Instruments, Reagents & Kits
and Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 107: Italy Historic Review for Rapid Microbiology Testing
by Product - Instruments, Reagents & Kits and Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 108: Italy 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 109: Italy Current & Future Analysis for Rapid
Microbiology Testing by End-Use - Pharma & Biotech Companies,
Contract Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 110: Italy Historic Review for Rapid Microbiology Testing
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 111: Italy 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 112: Italy Current & Future Analysis for Rapid
Microbiology Testing by Method - Growth-based, Viability-based,
Cellular Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Table 113: Italy Historic Review for Rapid Microbiology Testing
by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 114: Italy 15-Year Perspective for Rapid Microbiology
Testing by Method - Percentage Breakdown of Value Sales for
Growth-based, Viability-based, Cellular Component-based,
Nucleic Acid-based and Other Methods for the Years 2012, 2020 &
2027
UNITED KINGDOM
Table 115: UK Current & Future Analysis for Rapid Microbiology
Testing by Product - Instruments, Reagents & Kits and
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 116: UK Historic Review for Rapid Microbiology Testing by
Product - Instruments, Reagents & Kits and Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 117: UK 15-Year Perspective for Rapid Microbiology
Testing by Product - Percentage Breakdown of Value Sales for
Instruments, Reagents & Kits and Consumables for the Years
2012, 2020 & 2027
Table 118: UK Current & Future Analysis for Rapid Microbiology
Testing by End-Use - Pharma & Biotech Companies, Contract
Research Organizations, Other End-Uses and Diagnostic
Laboratories & Hospitals - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 119: UK Historic Review for Rapid Microbiology Testing by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations, Other End-Uses and Diagnostic Laboratories &
Hospitals Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 120: UK 15-Year Perspective for Rapid Microbiology
Testing by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Contract Research Organizations,
Other End-Uses and Diagnostic Laboratories & Hospitals for the
Years 2012, 2020 & 2027
Table 121: UK Current & Future Analysis for Rapid Microbiology
Testing by Method - Growth-based, Viability-based, Cellular
Component-based, Nucleic Acid-based and Other Methods -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032734/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001